Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply

Eli Lilly and Novo Nordisk are boosting supply of their weight loss drugs, while Apple Watch's heart-monitoring tech was approved for use in clinical studies.